Forum: Clinical Trials
12-19-2008, 02:01 PM
|
Replies: 2
Views: 7,226
VentiRx Pharmaceuticals Commences Phase I...
VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
(posted on 04/12/2008)
First Selective TLR8 Agonist to...
|
Forum: Clinical Trials
12-19-2008, 01:59 PM
|
Replies: 2
Views: 7,226
|